Get the app!
Back to Trades
Sell4

CoreWeave, Inc.

CRWV

Total Value
$3.1M
Net $3.1M sold
Sales
$3.1M
14 transactions

Company Information

Company Name
CoreWeave, Inc.
Ticker Symbol
CRWV
CIK
0001769628

Insider Information

Role
Chief Development Officer
Officer
Location
LIVINGSTON, NJ

Filing Details

Filing Date
Feb 19, 2026
Transaction Date
Feb 17, 2026
Accession Number
0001769628-26-000084
Form Type
4
Net Trading Amount
-$3.1M

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Feb 17, 2026Class A Common Stock25,000C
Feb 17, 2026Class A Common Stock1,913$89.84Sale$171.9K
Feb 17, 2026Class A Common Stock7,931$90.65Sale$718.9K
Feb 17, 2026Class A Common Stock6,407$91.71Sale$587.6K
Feb 17, 2026Class A Common Stock5,860$92.71Sale$543.3K
Feb 17, 2026Class A Common Stock1,990$93.69Sale$186.4K
Feb 17, 2026Class A Common Stock853$94.60Sale$80.7K
Feb 17, 2026Class A Common Stock46$95.38Sale$4.4K
Feb 17, 2026Class A Common Stock8,315C
Feb 17, 2026Class A Common Stock636$89.84Sale$57.1K
Feb 17, 2026Class A Common Stock2,638$90.65Sale$239.1K
Feb 17, 2026Class A Common Stock2,131$91.71Sale$195.4K
Feb 17, 2026Class A Common Stock1,950$92.71Sale$180.8K
Feb 17, 2026Class A Common Stock661$93.69Sale$61.9K
Feb 17, 2026Class A Common Stock284$94.60Sale$26.9K
Feb 17, 2026Class A Common Stock15$95.38Sale$1.4K

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Feb 17, 2026Derivative25,000C
Feb 17, 2026Derivative8,315C

Footnotes

  1. (F1)Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
  2. (F2)The reported securities are directly held by the Canis Major 2025 GRAT, of which the reporting person is the sole trustee and beneficiary.
  3. (F3)The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025.
  4. (F4)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.19 to $90.18, inclusive.
  5. (F5)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.19 to $91.18, inclusive.
  6. (F6)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.19 to $92.18, inclusive.
  7. (F7)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.19 to $93.18, inclusive.
  8. (F8)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.19 to $94.16, inclusive.
  9. (F9)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.19 to $95.07, inclusive.
  10. (F10)The reported securities are directly held by the Canis Minor 2025 GRAT, of which the reporting person's spouse is the sole beneficiary and trustee.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.